CNS10-NPC for the Treatment of RP
Condition(s):Retinitis PigmentosaLast Updated:February 6, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Retinitis PigmentosaLast Updated:February 6, 2024Recruiting
Condition(s):Myopic Macular DegenerationLast Updated:July 18, 2016Withdrawn
Condition(s):Stargardt’s Macular DystrophyLast Updated:December 10, 2020Completed
Condition(s):Retinitis PigmentosaLast Updated:November 28, 2023Active, not recruiting
Condition(s):Stargardt’s Macular DystrophyLast Updated:November 13, 2020Completed
Condition(s):Age-Related Macular DegenerationLast Updated:November 13, 2020Completed
Condition(s):Dry Age Related Macular DegenerationLast Updated:February 8, 2024Terminated
Condition(s):Stargardt’s Macular DystrophyLast Updated:July 7, 2021Completed
Condition(s):Retinal Hemorrhage; Macular DegenerationLast Updated:August 8, 2016Withdrawn
Condition(s):Macular Degeneration; Stargardt’s Macular DystrophyLast Updated:January 31, 2018Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.